A Phase Ii, Open-Label, Randomized Trial of Durvalumab with Olaparib or Cediranib in Patients with Mismatch Repair–Proficient Colorectal or Pancreatic CancerAlberto Hernando,Ming Han,Olubukola Ayodele,Ben X. Wang,Farnoosh Abbas-Aghababazadeh,Maria Vila-Casadesús,Enrique Sanz-García,S.Y. Cindy Yang,Hal Berman,Ana Vivancos,Bernard Lam,Ilinca Lungu, Abdulazeez Salawu,Lee-Anne Stayner, Benjamin Haibe-Kains,Philippe L. Bedard,Lisa Avery, Albiruni R. Abdul Razak,Trevor J. Pugh,Anna Spreafico,Lillian L. Siu,Aaron Hansencrossref（2024）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
